-
Topping the Hyderabad billionaires in the Forbes roster is Murali Divi and family, securing the 33rd spot with a staggering net worth of $6.3 billion.
-
At the end of the inspection, a Form 483 was issued with one observation which is procedural in nature, it added.
-
Telangana government in collaboration with Aurobindo Pharma on Sunday inaugurated the high-end cancer care block at MNJ Cancer Hospital.
-
Aurobindo Pharma Foundation (APF) inaugurated and dedicated Vedasadanam Block to Sri Sankara Gurukula Veda Patasala located in Shameerpet, Medchal–Malkajgiri district
-
They were arrested under Prevention of Money Laundering Act following day-long questioning with them here at the Enforcement Directorate headquarters on Wednesday.
-
Hyderabad: Aurobindo Pharma said on Monday that it has acquired the domestic formulation business of Veritaz Healthcare on a slump sale basis. The transaction was agreed at a consideration of Rs 171 crore on a debt-free cash-free basis. The transaction comes into effect from April 1 and is expected to close by May 2022. This […]
-
Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]
-
Hyderabad: To ensure quality tertiary cancer care facilities are available for free of cost to needy patients, the Telangana government in collaboration with voluntary organisations is developing crucial medical infrastructure at city-based MNJ Cancer Hospital with a cost of over Rs. 95 crore. As part of these efforts, on Friday, which also coincides with World […]
-
New Delhi: Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (active pharmaceutical ingredient) manufacturing facility. The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a […]
-
This is the first oral antiviral approved by India, the UK agency, and also by the US Foods & Drugs Administration.
-
Hyderabad: Proving once again that Hyderabad is rightly called the pharmaceutical hub of India, three billionaires featured in the top 100 India Rich List are from this sector and from the city as well. Murali Divi of Divi Labs is the richest Hyderabadi and is ranked the 14th richest person in the country with 61 […]
-
This plant will augment the supply of oxygen to meet the growing requirements to treat critically-ill Covid patients
-
For the fiscal ended March this year, the company posted a net profit of Rs 5,333.83 crore.
-
Divi's Labs leads city chart followed by Aurobindo, Hetero and Dr Reddy's while Mukesh, Elon Musk tops India & world respectively
-
This year's edition to be held virtually
-
The company has received final approval from USFDA to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg
-
Lupin is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension.
-
Hyderabad company's arms Lyfius and Qule Pharma to set up three facilities with Rs 3,039 cr.
-
As per the USFDA, Marksans Pharma is recalling close to six lakh bottles of diabetes drug Metformin Hydrochloride extended-release tablets in strengths of 500 mg and 750 mg in the US market
-
The all-cash transaction which is valued at $550 million (4,048 crore) is expected to close by January 2021